首页> Cancer research> Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity.

Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity.

导出原文传递

翻译打印收藏纠错

第一作者： Laurent,Beziaud

第一单位： INSERM UMR1098, TIMC LabEx LipSTIC, Besançon, France. University of Bourgogne Franche-Comté, UMR1098, Besançon, France.

作者： Laurent,Beziaud ^[1] ; Laura,Mansi ^[2] ; Patrice,Ravel ^[3] ; Elodie Lauret,Marie-Joseph ^[1] ; Caroline,Laheurte ^[4] ; Laurie,Rangan ^[1] ; Francis,Bonnefoy ^[5] ; Jean-René,Pallandre ^[5] ; Laura,Boullerot ^[5] ; Clémentine,Gamonet ^[1] ; Sindy,Vrecko ^[1] ; Lise,Queiroz ^[5] ; Tristan,Maurina ^[6] ; Guillaume,Mouillet ^[6] ; Thierry Nguyen Tan,Hon ^[6] ; Elsa,Curtit ^[2] ; Bernard,Royer ^[7] ; Béatrice,Gaugler ^[5] ; Jagadeesh,Bayry ^[8] ; Eric,Tartour ^[9] ; Antoine,Thiery-Vuillemin ^[2] ; Xavier,Pivot ^[2] ; Christophe,Borg ^[2] ; Yann,Godet ^[1] ; Olivier,Adotévi ^[10]

作者单位： INSERM UMR1098, TIMC LabEx LipSTIC, Besançon, France. University of Bourgogne Franche-Comté, UMR1098, Besançon, France. ^[1] INSERM UMR1098, TIMC LabEx LipSTIC, Besançon, France. University of Bourgogne Franche-Comté, UMR1098, Besançon, France. Department of Medical Oncology, University Hospital of Besançon, Besançon, France. ^[2] IRCM - INSERM U1194, Institut de Recherche en Cancérologie de Montpellier, Equipe Bioinformatique et Biologie des Systèmes du Cancer, Montpellier, France. ^[3] INSERM UMR1098, TIMC LabEx LipSTIC, Besançon, France. EFS Bourgogne Franche-Comté, Plateforme de Biomonitoring, INSERM CIC1431, Besançon, France. ^[4] INSERM UMR1098, TIMC LabEx LipSTIC, Besançon, France. ^[5] Department of Medical Oncology, University Hospital of Besançon, Besançon, France. ^[6] INSERM UMR1098, TIMC LabEx LipSTIC, Besançon, France. Department of Pharmacology, University Hospital of Besançon, Besançon, France. ^[7] INSERM U1138, Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, Université Paris Descartes, Paris, France. ^[8] INSERM UMR970, Hôpital Européen Georges Pompidou, Paris, France. Department of Biological Immunology, Assistance Publique-Hôpitaux de Paris, Paris, France. University Paris Descartes, Sorbonne Paris Cité, Paris, France. ^[9] INSERM UMR1098, TIMC LabEx LipSTIC, Besançon, France. University of Bourgogne Franche-Comté, UMR1098, Besançon, France. Department of Medical Oncology, University Hospital of Besançon, Besançon, France. olivier.adotevi@univ-fcomte.fr. ^[10]